-

06:52:09 AM

Latest GSK Stock Market News

GSK - Glaxosmithkline plc

07/29/21 6:03 PM

NYSE : GSK

fda approval

GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps

GlaxoSmithKline plc (GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as a treatment for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This new indication for

RHEA-AI

neutral

07/26/21 9:38 AM

NYSE : GSK

Shingrix approved in the US for prevention of shingles in immunocompromised adults

GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who

RHEA-AI

neutral

06/29/21 1:04 PM

NYSE : GSK

TUMS® Fuels the Autoburn, a Road Trip to America's Spiciest Destinations, with Hot Food Expert Sean Evans

GlaxoSmithKline (LSE: GSK) (NYSE: GSK) – Get ready for a red hot American summer! In time for July 4, as restrictions lift, temperatures rise and Americans hit the road, TUMS®, America's #1 heartburn brand, is unveiling the best spicy dishes in each state

RHEA-AI

very positive

06/22/21 2:18 AM

Nasdaq, NYSE : HALO, GSK, PFE

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of "ultra-long-acting" medicines for HIV

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc ("GSK"), with Pfizer Inc. and Shionogi Limited as shareholders, and Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced a global collaboration and

RHEA-AI

neutral

05/18/21 9:00 AM

NYSE : GSK

Advil Teams Up with Actor and Comedian Anthony Anderson to Inspire People Everywhere to Reclaim Life's Possibilities After Vaccination

GSK Consumer Healthcare (LSE/NYSE: GSK) today announced Advil, a leading over-the-counter (OTC) pain reliever worldwide, is teaming up with Emmy-nominated star and producer, Anthony Anderson, for the launch of #AfterMyShot, a new campaign that aims to help

RHEA-AI

neutral

05/03/21 9:37 AM

NYSE : GSK

Voltaren Arthritis Pain Gel Empowers Early Morning Risers Living with Osteoarthritis

GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers a painful truth: for people with osteoarthritis (OA), mornings can be the most difficult part of the

RHEA-AI

neutral

04/22/21 4:33 PM

NYSE : GSK

FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved JEMPERLI (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on the company's Biologics License Application. JEMPERLI

RHEA-AI

positive

04/19/21 9:08 AM

NYSE : GSK

Advil to Reduce Plastic in Over 80 Million Bottles by 20% with New Sustainable Plastic Technology

GSK Consumer Healthcare (LSE/NYSE: GSK), the maker of Advil , today announced its commitment to reducing the plastic in over 80 million Advil bottles 1 by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By

RHEA-AI

neutral

04/15/21 9:00 AM

NYSE : GSK

GSK Global Head of Vaccine Research and Development Joins Viome To Tackle Chronic Diseases

Viome , a mission-driven systems biology company aiming to help individuals improve their health, today announced the appointment of Dr. Emmanuel Hanon as Global Head of Research and Development (R&D). Dr. Hanon is a healthcare veteran hailing from

RHEA-AI

neutral

04/01/21 11:11 AM

NYSE : GSK

Flonase teams up with Major League Baseball and World Series champion Cody Bellinger to change the game on allergy season

GSK Consumer Healthcare (LSE/NYSE: GSK) announced today that Flonase Allergy Relief (Flonase) is partnering with World Series champion and seasonal allergy-sufferer Cody Bellinger of the Los Angeles Dodgers as the new face of the brand's "Change The Game"

RHEA-AI

neutral